55I LLC’s DexCom DXCM Stock Holding History

55I LLC’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$280K	Buy	+3,472	New	+$294K	0.01%	510

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

55I LLC's DXCM Position: Q3 2022 in Review

55I LLC opened a new position in DexCom (DXCM) in Q3 2022: 3,472 shares worth $280K. The stake represents 0.01% of the portfolio and ranks #510 among its holdings.

794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

55I LLC held 3,472 shares of DexCom worth $280K as of Q3 2022.
DexCom was a new 55I LLC position in Q3 2022.
DexCom made up 0.01% of 55I LLC's portfolio in Q3 2022, its #510 holding.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.